bpc-157 human clinical evidence safety regulatory status BPC-157: What you need to know before you try it You are hearing more about BPC-157. Patients ask about it daily. Here are the most common questions answered. What is BPC-157? bpc-157 human clinical trials evidence
Description
B12 absorption occurs primarily in the terminal ileum via intrinsic factor-mediated uptake, with approximately 1% absorbed through passive diffusion at high doses
Never go larger than 27G for subcutaneous injection
Also, given peripherally, BPC 157 counteracts serotonin-syndrome, and has a particular increase in serotonin in substantia nigra, acutely and chronically (80)
Product information is provided for identification, handling, documentation and quality-control reference only
